NeuroOne Medical Technologies Corporation (NMTC)
USD 0.86
(0.0%)
USD 0.86
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -11.75 Million USD | -18.6% |
| 2022 | -9.91 Million USD | -0.46% |
| 2021 | -9.79 Million USD | -103.23% |
| 2020 | -4.85 Million USD | 16.09% |
| 2019 | -5.78 Million USD | -81.43% |
| 2018 | -4.14 Million USD | -4.4% |
| 2017 | -3.05 Million USD | -9267.05% |
| 2016 | -32.61 Thousand USD | -5.49% |
| 2015 | -30.91 Thousand USD | 13.92% |
| 2014 | -35.91 Thousand USD | -82.94% |
| 2013 | -25.09 Thousand USD | -42.95% |
| 2012 | -13.73 Thousand USD | 49.93% |
| 2011 | -27.42 Thousand USD | -353.81% |
| 2010 | -6044.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.82 Million USD | 15.21% |
| 2024 Q3 | -2.73 Million USD | 3.34% |
| 2024 Q1 | -3.33 Million USD | -7.4% |
| 2023 Q2 | -3.45 Million USD | -97.43% |
| 2023 FY | - USD | -18.6% |
| 2023 Q4 | -3.1 Million USD | 10.17% |
| 2023 Q1 | -1.74 Million USD | -30.39% |
| 2023 Q3 | -3.45 Million USD | -0.04% |
| 2022 Q3 | -2.72 Million USD | 9.94% |
| 2022 FY | - USD | -0.46% |
| 2022 Q4 | -1.34 Million USD | 50.88% |
| 2022 Q2 | -3.03 Million USD | -8.88% |
| 2022 Q1 | -2.78 Million USD | -6.23% |
| 2021 Q4 | -2.62 Million USD | 10.59% |
| 2021 FY | - USD | -103.23% |
| 2021 Q1 | -1.93 Million USD | -1771.22% |
| 2021 Q2 | -2.37 Million USD | -22.42% |
| 2021 Q3 | -2.93 Million USD | -23.44% |
| 2020 Q2 | -1.36 Million USD | 24.27% |
| 2020 Q1 | -1.8 Million USD | -34.38% |
| 2020 Q3 | -1.58 Million USD | -15.69% |
| 2020 FY | - USD | 16.09% |
| 2020 Q4 | -103.65 Thousand USD | 93.44% |
| 2019 Q1 | -1.07 Million USD | 4.06% |
| 2019 Q4 | -1.34 Million USD | 27.7% |
| 2019 Q3 | -1.85 Million USD | -22.51% |
| 2019 Q2 | -1.51 Million USD | -41.59% |
| 2019 FY | - USD | -81.43% |
| 2018 Q2 | -1.09 Million USD | 19.7% |
| 2018 Q4 | -1.11 Million USD | 4.4% |
| 2018 FY | - USD | -4.4% |
| 2018 Q3 | -1.16 Million USD | -6.84% |
| 2018 Q1 | -1.36 Million USD | -52.94% |
| 2017 FY | - USD | -9267.05% |
| 2017 Q4 | -889.52 Thousand USD | -0.56% |
| 2017 Q3 | -884.59 Thousand USD | -73.09% |
| 2017 Q2 | -511.05 Thousand USD | -181.73% |
| 2017 Q1 | -181.39 Thousand USD | -9245.6% |
| 2016 Q1 | -14.56 Thousand USD | -462.73% |
| 2016 Q2 | -4386.00 USD | 69.89% |
| 2016 Q4 | -1941.00 USD | 86.24% |
| 2016 Q3 | -14.1 Thousand USD | -221.66% |
| 2016 FY | - USD | -5.49% |
| 2015 FY | - USD | 13.92% |
| 2015 Q4 | -2589.00 USD | 86.13% |
| 2015 Q3 | -18.66 Thousand USD | -94.98% |
| 2015 Q2 | -9574.00 USD | 3.07% |
| 2015 Q1 | -9877.00 USD | -61.39% |
| 2014 Q3 | -16.01 Thousand USD | -348.96% |
| 2014 Q2 | -3568.00 USD | -38.13% |
| 2014 Q1 | -2583.00 USD | 45.39% |
| 2014 FY | - USD | -82.94% |
| 2014 Q4 | -6120.00 USD | 61.8% |
| 2013 Q2 | -2985.00 USD | -118.36% |
| 2013 Q4 | -4730.00 USD | 68.03% |
| 2013 Q3 | -14.79 Thousand USD | -395.64% |
| 2013 FY | - USD | -42.95% |
| 2013 Q1 | -1367.00 USD | 71.11% |
| 2012 Q1 | -15.45 Thousand USD | -274.65% |
| 2012 Q3 | -2286.00 USD | 58.58% |
| 2012 Q4 | -4731.00 USD | -106.96% |
| 2012 FY | - USD | 49.93% |
| 2012 Q2 | -5519.00 USD | 64.3% |
| 2011 Q3 | -1182.00 USD | 82.26% |
| 2011 Q4 | -4126.00 USD | -249.07% |
| 2011 Q1 | -547.00 USD | 89.48% |
| 2011 Q2 | -6662.00 USD | -1117.92% |
| 2011 FY | - USD | -353.81% |
| 2010 Q3 | -2779.00 USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | -5198.00 USD | -87.05% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 12.835% |
| Cerus Corporation | -26.53 Million USD | 55.698% |
| OrthoPediatrics Corp. | -8.38 Million USD | -40.269% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -12.021% |
| Talis Biomedical Corporation | -66.04 Million USD | 82.2% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 29.499% |
| Inogen, Inc. | -45.67 Million USD | 74.264% |
| Spectral AI, Inc. | -12.26 Million USD | 4.127% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 75.351% |
| CVRx, Inc. | -38.73 Million USD | 69.647% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -233.22% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 2.899% |
| Orthofix Medical Inc. | -86.98 Million USD | 86.485% |
| Venus Concept Inc. | -26.11 Million USD | 54.98% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 76.38% |
| Bioventus Inc. | -23.07 Million USD | 49.042% |
| BrainsWay Ltd. | -2.31 Million USD | -408.697% |
| Envoy Medical, Inc. | -18.23 Million USD | 35.541% |
| electroCore, Inc. | -17.76 Million USD | 33.806% |
| IceCure Medical Ltd | -15.25 Million USD | 22.927% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 76.37% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 30.255% |
| MaxCyte, Inc. | -44.12 Million USD | 73.359% |
| Nexalin Technology, Inc. | -5.69 Million USD | -106.534% |
| PAVmed Inc | -75.74 Million USD | 84.479% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 78.132% |
| RxSight, Inc. | -41.03 Million USD | 71.353% |
| Sight Sciences, Inc. | -49.41 Million USD | 76.21% |
| SI-BONE, Inc. | -34.44 Million USD | 65.871% |
| TELA Bio, Inc. | -40.63 Million USD | 71.068% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 79.835% |
| Treace Medical Concepts, Inc. | -39 Million USD | 69.863% |
| LivaNova PLC | 39.01 Million USD | 130.131% |
| 908 Devices Inc. | -34.02 Million USD | 65.449% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 89.37% |
| Nemaura Medical Inc. | -7.28 Million USD | -61.327% |
| NeuroPace, Inc. | -22.83 Million USD | 48.515% |
| LENSAR, Inc. | -8.71 Million USD | -34.909% |
| Apyx Medical Corporation | -18.11 Million USD | 35.093% |
| Cutera, Inc. | -136.56 Million USD | 91.391% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -247.81% |
| BioSig Technologies, Inc. | -28.15 Million USD | 58.24% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 567.249% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 43.99% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 103.065% |
| Axonics, Inc. | 7.77 Million USD | 251.202% |
| Outset Medical, Inc. | -153.78 Million USD | 92.356% |
| IRIDEX Corporation | -7.44 Million USD | -57.841% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 88.016% |
| IRadimed Corporation | 20.8 Million USD | 156.517% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -45.82% |
| INVO Bioscience, Inc. | -6.88 Million USD | -70.871% |
| Telesis Bio, Inc. | -40.49 Million USD | 70.968% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 132.053% |
| Varex Imaging Corporation | 67.2 Million USD | 117.494% |
| Quipt Home Medical Corp. | 44.07 Million USD | 126.675% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -8.151% |
| Pulmonx Corporation | -55.09 Million USD | 78.661% |
| Dynatronics Corporation | -976 Thousand USD | -1104.497% |
| Modular Medical, Inc. | -17.1 Million USD | 31.264% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 18.84% |
| Semler Scientific, Inc. | 23.58 Million USD | 149.837% |
| InMode Ltd. | 196.28 Million USD | 105.989% |
| Bruker Corporation | 599 Million USD | 101.963% |
| Cytosorbents Corporation | -28.81 Million USD | 59.196% |
| DexCom, Inc. | 916.7 Million USD | 101.282% |
| Align Technology, Inc. | 799.03 Million USD | 101.471% |
| Viveve Medical, Inc. | -20.61 Million USD | 42.979% |
| ZimVie Inc. | 91.07 Million USD | 112.908% |
| Movano Inc. | -29.12 Million USD | 59.636% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -166.697% |
| Nexalin Technology, Inc. | -5.69 Million USD | -106.534% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -233.22% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 93.961% |
| Profound Medical Corp. | -27.12 Million USD | 56.657% |
| Insulet Corporation | 323.6 Million USD | 103.633% |
| enVVeno Medical Corporation | -25.01 Million USD | 53.01% |
| Surmodics, Inc. | 1.18 Million USD | 1089.561% |
| iCAD, Inc. | -6.56 Million USD | -79.071% |
| Nuwellis, Inc. | -16.35 Million USD | 28.124% |
| Biotricity, Inc. | -8.82 Million USD | -33.163% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 87.863% |
| Aethlon Medical, Inc. | -11.84 Million USD | 0.786% |
| InspireMD, Inc. | -20.91 Million USD | 43.781% |
| PAVmed Inc. | -75.74 Million USD | 84.479% |
| BIOLASE, Inc. | -15.13 Million USD | 22.346% |
| Beyond Air, Inc. | -59.03 Million USD | 80.085% |
| FONAR Corporation | 28.25 Million USD | 141.612% |
| AxoGen, Inc. | -13.32 Million USD | 11.795% |
| Vivani Medical, Inc. | -26.6 Million USD | 55.818% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 147.903% |
| Inari Medical, Inc. | 7.11 Million USD | 265.275% |
| UFP Technologies, Inc. | 72.74 Million USD | 116.161% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -247.216% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -90.968% |
| Tenon Medical, Inc. | -15.52 Million USD | 24.292% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 22.992% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 71.656% |
| AdaptHealth Corp. | -171.09 Million USD | 93.129% |
| Sintx Technologies, Inc. | -6.6 Million USD | -78.121% |
| NanoVibronix, Inc. | -3.43 Million USD | -242.241% |
| Quanterix Corporation | -38.08 Million USD | 69.135% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -8.151% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 39286.613% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 95.76% |
| TransMedics Group, Inc. | -7.6 Million USD | -54.623% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 45.987% |
| NeuroMetrix, Inc. | -7.09 Million USD | -65.675% |
| Hyperfine, Inc. | -47.06 Million USD | 75.02% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 79.838% |
| Biomerica, Inc. | -5.99 Million USD | -96.162% |
| Bone Biologics Corporation | 479.57 Thousand USD | 2551.349% |
| AVITA Medical, Inc. | -39.56 Million USD | 70.289% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -28.16% |
| Silk Road Medical, Inc | -45.08 Million USD | 73.922% |